NLRP3 and diabetic kidney disease: found that DsbA-L attenuated NLRP3-mediated renal inflammatory injury by promoting AMPK phosphorylation in DKD 88, which suggested that MAM acted as an inflammatory regulator through NLRP3 in DKD.